Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESAs we move towards Integrated Care Systems (ICSs) in England, we will be discussing the key changes in the NHS which are shaping the provision of current and future health and social care. In this blog, we will be exploring what ICSs are, their core purpose and ambitions and how data is going to be a key asset to improving patient outcomes in this new and ‘localised’ service delivery model.
ICSs have evolved from Sustainability and Transformation Partnerships (STPs) and will guide how health and care services are planned, paid for and delivered. ICSs are a key part of the NHS long-term plan and provide geographical regions with more autonomy to manage the health of their respective populations.
As of November 2020, there are currently 18 ICSs which are operational and cover around 50% of England’s population. The national aim is to have all 42 ICSs formed by April 2021 – a bold yet achievable challenge!
At its core, integration of care means joining up hospital and community-based services, physical and mental health and health and social care. Providers and commissioners of NHS services will integrate with local authorities and partners to collectively plan and collaborate on service delivery. Involving local authorities in these decisions means there is potential to drive improvements in population health by tackling the wider determinants of health that drive longer-term health outcomes and inequalities.
In recognition that it might be challenging to deliver changes in services to meet the distinctive needs and characteristics of local populations, the delivery of health care within an ICS is through smaller partnerships centred around more local areas and populations. A ‘three-tiered’ model has been designed:
Autonomy of Systems creates a mechanism for geographical regions to address their own health challenges, which will hopefully tackle health inequalities across England. For instance, yearly healthcare costs in England relating to cardiovascular disease (CVD) are estimated at £7.4 billion, with an annual cost to the wider economy of £15.8 billion, but there is known variation in the mortality outcomes in CVD - the death rate in Manchester is four times higher than that for Mid Suffolk. A nationwide CVD policy may not address the regional challenges and therefore a more localised strategy at a System level might be the best way to tackle some of the geographical health inequalities.
As the NHS moves more comprehensively towards an integrated care model, existing data and digital transformations combined with an “improvement mindset” could result in tangible differences to a patient’s experience and their access to best available care. Data is all around us in healthcare and we must continue to use it wisely to improve the outcomes for patients.
NHS resources are scarce. It is therefore imperative that inefficiencies are ironed out and we create a model which avoids ‘waste’. Using available data, it is possible to reduce ‘waste’ across a pathway by streamlining the internal administration process, scheduling of theatres and consultant rostering or even identifying pathway variation across a System. We have seen this happen most recently with the response to the current COVID-19 pandemic – harnessing available data meant we could map patient location to treatment centre, then identify a more efficient process to allow patients to receive care closer to home, and tertiary centres to treat the most critical patients.
NHSX are a joint unit to drive the digital transformation of care, which has been accelerated by COVID-19. Technology means an outpatient appointment is often no longer the fastest or most accurate way of providing specialist advice on diagnosis or ongoing patient care. NHS services will be redesigned so that over the next five years patients will be able to avoid up to a third of face-to-face outpatient visits, removing the need for up to 30 million outpatient visits a year. The digitalisation of the service will also allow PCNs to proactively identify ‘at-risk’ patients from healthcare records and deliver services based around either prevention rather than treatment or earlier detection and intervention to treat undiagnosed disorders.